Multiple sclerosis (MS) prevalence rises with countries’ prosperity, according to a new study, and occurs more in developed countries.
Researchers used data from 195 countries that was collected in...
Tysabri (natalizumab) significantly reduces disease activity and the number of relapses in people with paediatric-onset multiple sclerosis (POMS), new real-world study from Portugal has found....
A new nine-year study has found that abnormalities seen on MRI scans in children with multiple sclerosis (MS) at the onset of the condition, and within the first two years, might predict how their...
People living with multiple sclerosis who have bigger issues with mobility are more likely to have worse outcomes from Covid-19, new research has found.
Worse outcomes were also found to be more...
A new study has found that regular Pilates practice can improve balance and posture in men with multiple sclerosis (MS) which helps lessen the risk of falls and injuries.
Researchers in Iran enrolled...
A new trial to assess whether drugs already on the market can be used to treat and halt progressive multiple sclerosis (MS) is set to take place.
The new world-class Octopus clinical trial will...
Researchers are looking for people who found it difficult to return to work or school after receiving a diagnosis of multiple sclerosis (MS) or Covid-19 to take part in a survey to gather data on the...
The Bladder and Bowel Community has announced that its Just Can’t Wait card is going fully digital from this month.
The Community issues free cards for people living with bladder and bowel problems,...
A new analysis has found that people with multiple sclerosis (MS) who take Mavenclad (cladribine) do mount a protective antibody response to the seasonal influenza vaccine, and the varicella zoster...
Spending more time in the sun during summer is strongly protective for very early-onset multiple sclerosis (MS), as is residing in a sunnier location, according to a new study which was presented at...
